Nefropatía diabética

Ritchie, 1957, The pathology of Armani-Ebstein diabetic nephropathy, Am J Path, 33, 1.035 1999, U.S. Renal Data System, National Digestive and Kidney Diseases. United States Renal Data System Coordinating Center 1999 Annual Data Report Estudio CALVIDIA. Datos pendientes de publicación Chrisanthus, 1993, Type I Diabetic Nephropathy: Clinical characteristics and economic impact, J Diab Comp, 7, 15, 10.1016/1056-8727(93)90019-U Hasslacher, 1989, Similar risks of nephropathy in patients with type I or type II diabetes mellitus, Nephrol Dial Transpl, 4, 859, 10.1093/ndt/4.10.859 Mogensen, 1983, The stage in diabetic nephropaty, Diabetes, 32, S64, 10.2337/diab.32.2.S64 Mogensen, 1984, Predicting diabetic nephropathy in insulin-dependent patients, N Engl J Med, 311, 89, 10.1056/NEJM198407123110204 Viberti, 1982, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus, Lancet, i, 1.430, 10.1016/S0140-6736(82)92450-3 Parving, 1982, Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion, Acta Endocrinol, 100, 550, 10.1530/acta.0.1000550 Rodby, 1997, Type II diabetic nephropathy: its clinical course and therapeutic implications, Seminars in Nephrology, 2, 132 Olsen, 1996, How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature, Diabetologia, 39, 1.638, 10.1007/s001250050628 Thomsen, 1984, Renal changes in long-term type I (insulin dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material, Diabetologia, 26, 361, 10.1007/BF00266037 Castellino, 1990, Hyperfiltration and diabetic nephropathy: it is the beginning? Or is it the end??, Semin Nephrol, 10, 228 Parving, 1988, Prevalence of microalbuminuria arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes, Br Med J, 296, 156, 10.1136/bmj.296.6616.156 1993, The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Krolewski, 1995, Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus, N Engl J Med, 332, 1.251, 10.1056/NEJM199505113321902 Shankland, 1994, Expression of transforming growth factor-(1 during diabetic renal hypertrophy, Kidney Int, 46, 430, 10.1038/ki.1994.291 Larkins, 1992, The link between hyperglycemia and diabetic nephropathy, Diabetologia, 35, 499, 10.1007/BF00400475 Brownlee, 1993, Lilly Lecture 1993. Glycation and diabetes complications, Diabetes, 43, 836, 10.2337/diab.43.6.836 Greene, 1987, Sorbitol phosphoinositides, and sodium-potasium-ATPase in the pathogenesis of diabetes complications, N Engl J Med, 316, 599, 10.1056/NEJM198703053161007 1997, Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, Sixth report. Arch Intern Med, 157, 2.413, 10.1001/archinte.1997.00440420033005 1998, Documento de consenso sobre las pautas de detección y tratamiento de la nefropatía diabética en España. Elaborado por el comité de expertos de las Sociedades Españolas de Diabetes, Endocrinología, Medicina Familiar y Comunitaria y de Nefrología, Atención Primaria, 21, 103 1988, American Diabetes Association. Physicians Guide to Insulin-Dependent (type I) Diabetes: Diagnosis and Treatment 1988, American Diabetes Association. Physicians Guide to Non-Insulin-Dependent (type II) Diabetes: Diagnosis and Treatment Zeller, 1991, Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus, N Engl J Med, 324, 78, 10.1056/NEJM199101103240202 Parving, 1983, Early aggressive antihypertensive treatment treatment reduces rate of decline in kidney function in diabetic nephropathy, Lancet, i, 1.175, 10.1016/S0140-6736(83)92462-5 1998, Effects of intensive blood-pressure lowering and dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) Randomized Trial, Lancet, 351, 1.755, 10.1016/S0140-6736(98)04311-6 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, BMJ, 317, 703, 10.1136/bmj.317.7160.703